Ageing is associated with diminished apoptotic cell clearance in vivo

Ageing leads to immune system dysfunction and the accumulation of autoantibodies. Because the rapid phagocytic clearance of apoptotic cells is required to prevent the development of autoimmunity, we examined the relative clearance of apoptotic material in young and aged mice using two independent assays. First, 2‐year‐old mice were found to be impaired in their ability to clear apoptotic keratinocytes following ultraviolet irradiation of the skin. Secondly, peritoneal macrophages exposed to apoptotic Jurkat T cells in vivo displayed diminished phagocytic activity in aged mice compared with 8‐week‐old mice. Consistent with these findings, aged mice exhibited signs of autoimmunity with the appearance of anti‐nuclear antibodies and increased kidney glomerular size as well as complement deposits within the glomeruli. In vitro assays revealed that the pretreatment of macrophages with the serum from aged mice led to a reduction in their ability to phagocytose apoptotic bodies compared with macrophages treated with serum from young mice. These data show that the ageing process is accompanied by a diminished ability to clear apoptotic debris. This accumulation of apoptotic debris could contribute to immune system dysfunction that occurs in aged organisms.

[1]  Terry M Therneau,et al.  Prevalence of monoclonal gammopathy of undetermined significance. , 2006, The New England journal of medicine.

[2]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[3]  Paul A. C. Cloos,et al.  Post-Translational Modifications of Proteins: Implications for Aging, Antigen Recognition, and Autoimmunity , 2004, Biogerontology.

[4]  J. Katz,et al.  Innate immunity in aging: impact on macrophage function , 2004, Aging cell.

[5]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[6]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[7]  P. Butler,et al.  Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.

[8]  M. Rowley,et al.  Reciprocal change with age in antibody to extrinsic and intrinsic antigens. , 1968, Lancet.

[9]  V. Gilbertsen,et al.  Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. , 1973, Journal of immunology.

[10]  M. Walport,et al.  Hereditary deficiency of C3 in animals and humans. , 1993, International reviews of immunology.

[11]  M. Ramos-Casals,et al.  Systemic autoimmune diseases in elderly patients: atypical presentation and association with neoplasia. , 2004, Autoimmunity reviews.

[12]  T. Fleisher,et al.  A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome. , 2002, Clinical immunology.

[13]  E. Kovacs,et al.  The aging innate immune system. , 2005, Current opinion in immunology.

[14]  D. Choubey,et al.  Resistance to UV‐induced apoptosis in human keratinocytes during accelerated senescence is associated with functional inactivation of p53 , 2004, Journal of cellular physiology.

[15]  T. Möröy,et al.  Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.

[16]  S. Kihara,et al.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.

[17]  D. Steinberg,et al.  Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Prelog Aging of the immune system: a risk factor for autoimmunity? , 2006, Autoimmunity reviews.

[19]  D. Finegood,et al.  A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. , 2006, Journal of autoimmunity.

[20]  J. Charles Jennette,et al.  Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase , 2002, The Journal of experimental medicine.

[21]  D. Steinberg,et al.  Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Voll,et al.  SLE--a disease of clearance deficiency? , 2005, Rheumatology.

[23]  K. Tanaka,et al.  Evaluation of apoptotic cells induced by ultraviolet light B radiation in epidermal sheets stained by the TUNEL technique. , 1999, The Journal of investigative dermatology.

[24]  J. Piette,et al.  Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. , 2004, Arthritis and rheumatism.

[25]  Faten Gad,et al.  Mechanisms and implications of the age‐associated decrease in DNA repair capacity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  M. Marshall ENZYMATIC OR PHARMACOLOGICAL FIBRINOLYSIS? , 1964, Lancet.

[27]  P. Taylor,et al.  A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.

[28]  D. Aw,et al.  Immunosenescence: emerging challenges for an ageing population , 2007, Immunology.

[29]  Takafumi Ogawa,et al.  Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages , 2000, Mechanisms of Ageing and Development.

[30]  C. Langford Vasculitis in the geriatric population. , 2005, Clinics in geriatric medicine.

[31]  W. Janssen,et al.  Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte , 2005, Cell.

[32]  B. Gilchrest,et al.  Topically applied diacylglycerols increase pigmentation in guinea pig skin. , 1995, The Journal of investigative dermatology.

[33]  J. Lord,et al.  Neutrophil ageing and immunesenescence , 2001, Mechanisms of Ageing and Development.

[34]  A. Agar,et al.  Effect of L‐Arginine on Age‐Related Changes in Macrophage Phagocytic Activity , 2004, Immunological investigations.

[35]  Annalisa Capobianco,et al.  Cutting Edge: Dissociation Between Autoimmune Response and Clinical Disease After Vaccination with Dendritic Cells , 2003, The Journal of Immunology.

[36]  P. Linton,et al.  Age-related changes in lymphocyte development and function , 2004, Nature Immunology.

[37]  A. Kavanaugh,et al.  Rheumatic disease in the elderly: rheumatoid arthritis. , 2005, Clinics in geriatric medicine.

[38]  S. Akira,et al.  Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production1 , 2007, The Journal of Immunology.

[39]  R. Coppo,et al.  Circulating Fc-receptor blocking factors in IgA nephropathies. , 1985, Clinical nephrology.

[40]  K. Takahashi,et al.  Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype , 2005, The Journal of Immunology.

[41]  T. Fleisher,et al.  A composite picture of TcRα/β+ CD4-CD8- T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome , 2002 .

[42]  E. Deconinck,et al.  A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunity. , 2003, Journal of hematotherapy & stem cell research.

[43]  P. Weiner,et al.  Decline in mitogen induced proliferation of lymphocytes with increasing age. , 1987, Clinical and experimental immunology.

[44]  M. Walport,et al.  Lupus-Prone Mice Have an Abnormal Response to Thioglycolate and an Impaired Clearance of Apoptotic Cells 1 , 2003, The Journal of Immunology.

[45]  T. Horiuchi,et al.  Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.

[46]  R. Voll,et al.  Impaired clearance of dying cells in systemic lupus erythematosus. , 2005, Autoimmunity reviews.